• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

二氢麦角胺改善阿尔茨海默病状态下的突触萎缩及其对认知功能的影响

陈佩佩, 魏杰, 柳晓泉, 刘昊晨

陈佩佩, 魏杰, 柳晓泉, 刘昊晨. 二氢麦角胺改善阿尔茨海默病状态下的突触萎缩及其对认知功能的影响[J]. 中国药科大学学报, 2023, 54(4): 501-510. DOI: 10.11665/j.issn.1000-5048.2023032002
引用本文: 陈佩佩, 魏杰, 柳晓泉, 刘昊晨. 二氢麦角胺改善阿尔茨海默病状态下的突触萎缩及其对认知功能的影响[J]. 中国药科大学学报, 2023, 54(4): 501-510. DOI: 10.11665/j.issn.1000-5048.2023032002
CHEN Peipei, WEI Jie, LIU Xiaoquan, LIU Haochen. Dihydroergotamine ameliorates synaptic atrophy in Alzheimer’s disease states and its effect on cognitive function[J]. Journal of China Pharmaceutical University, 2023, 54(4): 501-510. DOI: 10.11665/j.issn.1000-5048.2023032002
Citation: CHEN Peipei, WEI Jie, LIU Xiaoquan, LIU Haochen. Dihydroergotamine ameliorates synaptic atrophy in Alzheimer’s disease states and its effect on cognitive function[J]. Journal of China Pharmaceutical University, 2023, 54(4): 501-510. DOI: 10.11665/j.issn.1000-5048.2023032002

二氢麦角胺改善阿尔茨海默病状态下的突触萎缩及其对认知功能的影响

基金项目: 国家自然科学基金资助项目(No.81903703)

Dihydroergotamine ameliorates synaptic atrophy in Alzheimer’s disease states and its effect on cognitive function

Funds: This study was supported by the National Natural Science Foundation of China (No.81903703)
  • 摘要: 研究表明突触损伤与认知功能障碍密切相关,狐猴酪氨酸激酶1(LMTK1)是影响突触生长的关键性激酶。二氢麦角胺(DHE)是一种生物活性较高的麦角生物碱衍生物,它对认知、记忆处理和运动控制具有一定的调节作用。本研究旨在探讨DHE对阿尔茨海默病(AD)模型动物突触形态和可塑性及认知功能的影响。4月龄SAMR1小鼠作为对照(n = 12),4月龄SAMP8小鼠被随机分为3组(每组12只):AD组、DHE低剂量组以及高剂量组,连续8周每日腹腔注射DHE注射液或生理盐水。采用免疫荧光、高尔基染色、电生理、Morris水迷宫以及Western blot实验研究DHE对AD模型小鼠突触形态、突触可塑性、认知功能以及LMTK1下游TBC1D9B磷酸化水平的影响。构建沉默和过表达LMTK1的C17.2细胞,运用免疫荧光实验研究DHE对LMTK1沉默和过表达后神经细胞突触长度的影响。免疫荧光实验结果显示SAMP8小鼠给予DHE后,突触后标记物PSD95显著增加,这提示DHE可以增加AD小鼠海马体突触密度;高尔基染色实验结果表明,AD模型小鼠海马内突触发生萎缩,而高剂量组DHE显著改善了突触萎缩;电生理实验结果表明,与正常小鼠相比,AD模型小鼠长时程增强(LTP)水平明显降低(P < 0.000 1),而DHE给药后LTP显著改善;Morris水迷宫实验结果进一步表明,DHE可以改善AD小鼠的认知障碍;Western blot实验结果表明,AD小鼠海马内P-LMTK1水平显著增加,DHE给药后,其下游效应蛋白P-TBC1D9B水平显著降低;体外细胞免疫荧光实验结果表明,DHE显著改善了过表达LMTK1的神经细胞的突触萎缩,而当LMTK1沉默后,其改善作用消失。本研究提示DHE可能通过作用于LMTK1改善AD状态下的突触萎缩及认知功能障碍。
    Abstract: Studies suggest that synaptic damage is closely associated with cognitive dysfunction, and lemur tyrosine kinase 1 (LMTK1) is a key kinase that affects synaptic growth. Dihydroergotamine (DHE) is an ergot alkaloid derivative with high biological activity, which could regulate cognition, memory processing and motor control.This study aims to investigate the effect of DHE on synapse atrophy and plasticity as well as cognition in Alzheimer’s disease (AD) model animals.SAMR1 mice were selected as control group (n = 12).SAMP8 mice were randomly divided into 3 groups (n = 12 for each group):AD group, DHE low-dose group and high-dose group.The DHE groups were injected DHE intraperitoneally daily for 8 weeks.Immunofluorescence experiments, Golgi staining experiment, electrophysiological experiment, Morris water maze experiment (MWM) and Western blot experiment were conducted to investigate the effect of DHE on synaptic morphology, synaptic plasticity, cognitive function as well as the phosphorylation level of LMTK1 downstream TBC1D9B in AD model mice.Subsequently, the LMTK1 silencing and overexpression cells were constructed.Immunofluorescence experiments were used to study the effect of DHE on synaptic length of nerve cell after LMTK1 silencing and overexpression.In the hippocampus of AD mice, the postsynaptic marker PSD95 was significantly increased after DHE administration, which suggested that DHE could increase the synaptic density. In Golgi staining experiment, synaptic atrophy was observed in the hippocampal of AD mice, which could be improved by high-dose DHE.Compared with normal mice, the long-term potentiation (LTP) level of AD model mice was significantly reduced (P < 0.000 1), DHE could increase LTP significantly.The MWM experiment further showed that DHE could improve cognitive function in AD mice.WB experiments showed that the level of P-LMTK1 in the hippocampus of AD mice increased significantly, and the level of downstream P-TBC1D9B decreased significantly after DHE administration.Cell immunofluorescence experiments in vitro had shown that DHE significantly improved synaptic atrophy in overexpressed C17.2 cells, while its improvement disappeared when LMTK1 was silenced. This research suggests DHE may improve synaptic atrophy and cognitive dysfunction in AD by targeting on LMTK1.
  • [1] . Front Aging Neurosci, 2022, 14: 9374-9386.
    [2] Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease [J]. Lancet, 2021, 397(10284): 1577-1590.
    [3] John A, Reddy PH. Synaptic basis of Alzheimer’s disease: focus on synaptic amyloid beta, P-tau and mitochondria[J]. Ageing Res Rev, 2021, 65: 101208.
    [4] Nishino H, Saito T, Wei R, et al. The LMTK1-TBC1D9B-Rab11A cascade regulates dendritic spine formation via endosome trafficking[J]. J Neurosci, 2019, 39(48): 9491-9502.
    [5] Takano T, Urushibara T, Yoshioka N, et al. LMTK1 regulates dendritic formation by regulating movement of Rab11A-positive endosomes[J]. Mol Biol Cell, 2014, 25(11): 1755-1768.
    [6] Wang Y, Aun R, Tse FL.Brain uptake of dihydroergotamine after intravenous and nasal administration in the rat[J].Biopharm Drug Dispos, 1998, 19(9): 571-575.
    [7] Hollister LE, Yesavage J. Ergoloid mesylates for senile dementias: unanswered questions[J]. Ann Intern Med, 1984, 100(6): 894-898.
    [8] Kemali M, Kemali D. Lysergic acid diethylamide: morphological study of its effect on synapses[J]. Psychopharmacology, 1980, 69(3): 315-317.
    [9] Rivera-Mancilla E, Avilés-Rosas VH, Manrique-Maldonado G, et al. The role of α1- and α2-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats[J]. J Headache Pain, 2017, 18(1): 104.
    [10] Silberstein SD, Shrewsbury SB, Hoekman J. Dihydroergotamine (DHE) — then and now: a narrative review[J]. Headache, 2020, 60(1): 40-57.
    [11] Boudreaux SP, Duren RP, Call SG, et al.Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia[J]. Leukemia, 2019, 33(1): 52-63.
    [12] Zhao HM, Wei J, Du YN, et al.Improved cognitive impairments by silencing DMP1 via enhancing the proliferation of neural progenitor cell in Alzheimer-like mice[J]. Aging Cell, 2022, 21(5): e13601.
    [13] Zeng ML, Shang Y, Araki Y, et al. Phase transition in postsynaptic densities underlies formation of synaptic complexes and synaptic plasticity[J]. Cell, 2016, 166(5): 1163-1175.
    [14] Meyer D, Bonhoeffer T, Scheuss V. Balance and stability of synaptic structures during synaptic plasticity[J]. Neuron, 2014, 82(2): 430-443.
    [15] Magee JC, Grienberger C. Synaptic plasticity forms and functions[J]. Annu Rev Neurosci, 2020, 43: 95-117.
    [16] Pickett EK, Rose J, McCrory C, et al. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease[J].Acta Neuropathol, 2018, 136(5): 747-757.
    [17] Zhou Y, Song ZY, Han X, et al.Prediction of Alzheimer’s disease progression based on magnetic resonance imaging[J]. ACS Chem Neurosci, 2021, 12(22): 4209-4223.
    [18] Griciuc A, Federico AN, Natasan J, et al. Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation[J]. Hum Mol Genet, 2020, 29(17): 2920-2935.
    [19] Colom-Cadena M, Spires-Jones T, Zetterberg H, et al. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease[J]. Alzheimers Res Ther, 2020, 12(1): 21.
    [20] Grimmig B, Hudson C, Moss L, et al. Astaxanthin supplementation modulates cognitive function and synaptic plasticity in young and aged mice[J]. GeroScience, 2019, 41(1): 77-87.
    [21] Naslavsky N, Caplan S. The enigmatic endosome-sorting the ins and outs of endocytic trafficking[J]. J Cell Sci, 2018, 131(13): jcs216499.
    [22] Lai SM, Ng KY, Koh RY, et al. Endosomal-lysosomal dysfunctions in Alzheimer’s disease: pathogenesis and therapeutic interventions[J]. Metab Brain Dis, 2021, 36(6): 1087-1100.
    [23] Sultana P, Novotny J. Rab11 and its role in neurodegenerative diseases[J]. ASN Neuro, 2022, 14: 17590914221142360.
  • 期刊类型引用(1)

    1. 穆峣,赵慧敏,刘昊晨,柳晓泉. 阿尔茨海默病药物研发最新进展. 中国药科大学学报. 2024(06): 816-825 . 本站查看

    其他类型引用(0)

计量
  • 文章访问数:  368
  • HTML全文浏览量:  21
  • PDF下载量:  388
  • 被引次数: 1
出版历程
  • 收稿日期:  2023-03-19
  • 修回日期:  2023-08-07
  • 刊出日期:  2023-08-24

目录

    /

    返回文章
    返回